Article
Prevalent mutations in prostate cancer.
Journal of cellular biochemistry - 15 Feb 2006
Dong Jin-Tang
Abstract excerpt
Quantitative and structural genetic alterations cause the development and progression of prostate cancer. A number of genes have been implicated in prostate cancer by genetic alterations and functional consequences of the genetic alterations. These include the ELAC2 (HPC2), MSR1, and RNASEL (HPC1) genes that have germline mutations in familial prostate cancer; AR, ATBF1, EPHB2 (ERK), KLF6, mitochondria DNA, p53,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
